In addition, a recent study using a murine peritoneal carcinomatosis model showed that B-1 cells and their IgMs are required for the anti-cancer response induced by the combination of toll-like receptor and C-type lectin receptor agonists (32). The gene discussed is CLEC4D; the disease is cancer.